We use cookies to provide you with the best possible experience. By using Orbitax's services, you agree that we may store cookies on your device. Cookie Policy.
The AI assistant for tax questions
Track worldwide tax law changes daily
Cross-border tax analysis and data
Unify and empower your entity management
Provides compliance steps, forms & rates
Visualize and manage your entity data
Comprehensive compliance management
Audit and global tax controversy tracking
Manage reportable cross-border arrangements
Country-by-country reporting & compliance
Pillar 2 planning, reporting and compliance
Calculate US tax impact of foreign operations
Automated workflows for recurring tax tasks
Secure API connections to 3rd-party systems
Secure storage for your tax documentation
Automated tax workflows with secure APIs.
Collaborate securely on your tax data
Share This Article
|
|
The German Federal Fiscal Court reversed a lower court to rule that an income adjustment (constructive dividend) may apply to German distribution entities of foreign pharmaceutical multinationals with respect to so-called parallel imports of (original) pharmaceutical products in Germany.The ruling emphasizes that marketing activities by German distributors can create economic benefits for foreign parent entities with respect to parallel imports, potentially triggering an income adjustment due to saved marketing expenses.The court remanded the case to determine the specific amount of the income adjustment, indicating that the (pro rata) compensation received by the German distribution entity's sales force for the product...